Method of treatment of Heliobacter pylori infections with triclosan
US5286492A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Apr 30, 1991 |
| Grant date | Feb 15, 1994 |
| Priority date | — |
| Expiry date | Apr 30, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/085
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for the treatment of gastrointestinal disorders associated with Helicobacter pylori infections which comprises administering to a patient an orally effective amount of triclosan is disclosed. The triclosan may be administered in the form of powders, granules, spheroids or liquids, or in unit dosage form as capsules or tablets containing 1 to 100 mg, preferably 10 to 60 mg, of triclosan. The triclosan may also be administered in gastric sustained release medicaments either as raft forming tablets or liquids, optionally to be co-administered with a solid pharmaceutically acceptable carboxylic acid or acid salt, or as mucoadherent-coated granules or spheroids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.